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Abstract
Background/Aims: Hypertensive nephroangiosclerosis is associated with progressive increase 
of intrarenal vascular resistance. In addition to blood pressure, other factors can contribute to 
hypertensive renal damage including a prothrombotic state. We investigated the relationship 
between hemostatic markers and intrarenal vascular resistance in hypertension. Methods: 
In 115 untreated, nondiabetic, hypertensive subjects free of cardiovascular complications 
and advanced renal function impairment, we measured 24-hour creatinine clearance (GFR) 
and urinary albumin excretion (UAE), fasting plasma glucose, HOMA-index, and plasma 
levels of fibrinogen, D-dimer, prothrombin fragment 1+2, plasminogen activator inhibitor-1, 
homocysteine, and lipoprotein(a). In all patients, measurement of intrarenal resistance was 
obtained by renal Doppler ultrasound with calculation of the renal resistance index (RI). 
Results: Patients in the highest tertile of RI were older and had greater body mass index, 
pulse pressure, fibrinogen, and D-dimer levels and lower GFR than patients in the lowest 
RI tertile. RI was directly correlated with age, pulse pressure, HOMA-index, UAE, D-dimer, 
and inversely with GFR. On multivariate analysis, RRI was independently associated with age, 
GFR, and plasma D-dimer. Conclusions: A prothrombotic state is associated with increased 
intrarenal vascular resistance in nondiabetic hypertensive patients and might contribute to the 
early stages of hypertensive renal disease.
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IntroductionHypertensive nephroangiosclerosis is a common cause of end-stage renal failure and is associated with an increased risk of cardiovascular events [1]. This condition is characterized by narrowing of preglomerular arteries that is due to intimal thickening and hyalinosis of the vascular wall and is associated with progressive increase of intrarenal vascular resistance [2]. The structural changes of preglomerular vessels can cause glomerular ischemia thereby 
leading to progressive decline of glomerular filtration. In addition to high blood pressure, other conditions might concur to facilitate progression of intrarenal vascular damage 
including aging, race, male sex, smoking, plasma lipids and uric acid levels, proteinuria, and 
insulin resistance [3-5]. The extent of intrarenal vascular damage can be reliably assessed 
noninvasively by use of renal duplex Doppler ultrasound with measurement of the intrarenal 
resistance index (RI) [6, 7].
Additional cardiovascular risk factors beyond those traditionally identified in epidemiologic studies are possibly involved in the occurrence of hypertensive complications 
and are commonly referred to as “emergent” [8]. Among these emergent risk factors, a 
prothrombotic state has been repeatedly called into play [9]. In hypertension, an activated 
hemostatic system has been reported in association with cardiovascular events [10], 
functional changes of the left ventricle [11], thickening of the carotid artery intima-media 
[12], and impaired renal function [13]. We hypothesized that a prothrombotic state might 
contribute to the hypertension-related intrarenal vascular damage. Therefore, this study 
was designed to investigate the relationship of intrarenal RI with hemostasis markers in nondiabetic hypertensive patients free of cardiovascular complications.
Patients and Methods
Patients
One-hundred-fifteen patients with grade 1-2 essential hypertension who were consecutively referred to the Hypertension Clinic of our University were included in a cross-sectional study. The patients seen at 
our clinic are white, include individuals with all grades of hypertension who live in northeast Italy, and are representative of hypertensive patients in this geographical area [14]. Blood pressure was measured with 
an automated device (Omron M6, OMRON Healthcare Co., Kyoto, Japan) after each subject had been supine 
for 15 min and the average of 3 readings was recorded. Diagnosis of hypertension was established in all patients according to current guidelines [15].
Patients younger of 18 years and older than 80 years and pregnant women were excluded, together 
with patients with diabetes, secondary hypertension, body mass index (BMI) of more than 35 kg/m2, 24-
hour creatinine clearance (GFR) of less than 30 ml/min/1.73 m2, use of drugs that could interfere with the 
hemostatic system, and history of acute illness, stroke, transitory ischemic attack, ischemic heart, cardiac 
valve, or other types of heart and peripheral artery disease. Diabetes was excluded by measurement of 
fasting blood glucose, glycated hemoglobin, and standard oral glucose test [16]. Secondary forms of 
hypertension were excluded after extensive clinical and laboratory investigations that included duplicate 
measurements of GFR, plasma active renin and aldosterone, urinary cortisol and cathecolamines, and renal 
ultrasound examination [17]. Renal angio MRI/CT-scan and additional functional tests were performed 
when appropriate [18]. Cardiovascular complications were identified for exclusion by analysis of medical 
records, physical examination, ECG, echocardiography, and ultrasound examination of aorta, carotid, 
iliac, and femoral arteries. Additional evaluations included exercise testing, myocardial scintigraphy, and angiography and were done when indicated [14]. 
Sixty-two (54%) of 115 patients had never been treated with antihypertensive drugs. The remaining 
53 patients (46%) were treated with calcium-channel blockers (33%), angiotensin-converting enzyme 
inhibitors or angiotensin-receptor blockers (18%), beta-blockers (13%), diuretics (11%), and alpha-
blockers (5%). In all patients, antihypertensive drugs were washed-out for a minimum of 2 weeks before the study. All patients were closely monitored during the wash-out period and in those with blood pressure 
persistently higher than 180/110 mm Hg alpha-blockers and/or calcium-channel blockers were given. No 
patients were treated with lipid-lowering, anticoagulant, or anti-platelet drugs. Before evaluation, patients 
ate a standard diet to keep a sodium intake of 100-150 mmol/day that was checked with measurement 
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of sodium excretion in 24-hour urine collections. Patients were defined as smokers if they had smoked for at least 5 years and up to 1 year before the study and smoking habit was quantified by the average 
number of cigarettes/day. Alcohol intake was estimated by a questionnaire [19] as grams/day. The study 
was performed in accordance with the principles of the Declaration of Helsinki and received approval from 
the local Institutional Review Board. Informed consent was obtained from all patients.
Renal function studies and renal imaging
Renal function studies included assessment of GFR by duplicate collections of 24-hour creatinine 
clearance and 24-hour urinary albumin excretion (UAE). Ultrasound examination by a duplex Doppler 
apparatus was performed after a 12 hour fasting, as described previously [20]. All measurements were 
obtained by experienced operators and tracings were examined by an experienced reader who was blinded 
to any clinical information of the patients. Doppler scans were performed using a 3.5 MHz convex phased-
array probe and color Doppler mapping in order to identify the renal arteries. Measurements were collected 
with patients in lateral decubitus position through the flank, using the liver as an acoustic window whenever 
possible. The Doppler angle was always lower than 60° and as close as possible to 0°; specific care was taken 
not to compress the kidney. Peak systolic velocity [Vmax (cm/sec)] and end diastolic velocity [Vmin (cm/
sec)] were obtained for the calculation of RI (Vmax-Vmin/Vmax) [6]. This parameter was calculated from 
Doppler measurements obtained by placing the sample volume at the level of the color signals visualized 
on the interlobar arteries, along the edge of medullary pyramids. The average of 4 to 6 homogeneous 
measurements from the upper, middle, and lower third of both kidneys was considered. The intraobserver 
and interobserver coefficient of variability for IR were 6.6% and 8.3%, respectively.
Laboratory measurementsA sample of venous blood was obtained from each patient in the sitting position in the morning after an overnight fast and without venous stasis. Blood was collected into silicone-treated glass tubes and 
plasma was separated and frozen at -80 °C until assayed. Plasma fibrinogen, D-dimer, prothrombin fragment 
1+2 (F1+2), and plasminogen-activator inhibitor-1 (PAI-1) were determined as reported previously 
[14, 18]. Briefly, plasma fibrinogen was measured by a functional assay in an automatic coagulometer 
autoanalyzer (intra-assay and inter-assay coefficient of variation: 5.1 and 6.8%, respectively); fibrin 
D-dimer was measured immunoenzymatically (intra-assay and inter-assay coefficient of variation: 5.3 and 
7.1%, respectively); F1+2 plasma levels were evaluated by ELISA (intra-assay and inter-assay coefficient 
of variation: 5.5 and 11.2%, respectively); PAI-1 was assayed by enzyme immunoassay (intra-assay and 
inter-assay coefficient of variation: 4.6 and 6.8%, respectively). Plasma homocysteine was determined by a 
nephelometric method (intra-assay and inter-assay coefficient of variation: 7.0 and 8.2%, respectively) [21] 
and plasma concentration of lipoprotein(a) by the Macra® Lp(a) enzyme linked immunosorbent assay  kit 
(intra-assay and inter-assay coefficient of variation: from 2 to 7% and from 6 to 9%, respectively) [18]. All measurements were done in duplicate.
Statistical analysis
Values are expressed as mean ± standard deviation for normally distributed variables, with median 
and interquartile range used for variables with skewed distributions. Normality of distribution was 
assessed with the Kolmogorov-Smirnov test, and variables with skewed distribution were analyzed after 
logarithmic transformation. The Student’s t test was used for comparison between two independent groups and analysis of variance for comparison among more than two groups with Bonferroni correction. The 
Pearson χ2 test was used to compare categorical variables. Relationships between continuously distributed 
variables were examined by linear regression analysis and the correlation was expressed by the Pearson’s 
correlation coefficient. Multivariate linear regression analysis was performed to identify which variables 
were independently associated with RI. Two-tailed probability value of less than 5% was considered to 
indicate statistical significance. All data analyses were performed using Stata 9.2 (StataCorp LP, TX, USA).
Results
One-hundred-fifteen hypertensive patients (age 46±13 years; 63 men, 52 women; 62 
treatment-naïve) were enrolled. Clinical characteristics of the study patients are summarized 
in Table 1, where patients are also grouped according to tertiles of renal RI. Patients in the 
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highest tertile of RI were significantly older, had greater BMI and pulse pressure, but no 
significant difference in sex distribution, duration of hypertension, smoking habits, daily 
alcohol consumption, and frequency of use of different classes of antihypertensive drugs.
As shown in Table 2 and as expected, increasing intrarenal RI was associated with 
progressive decline in GFR, whereas no association was observed with UAE, mostly because 
microalbuminuria (UAE >30 mg/d) was detected in only 19 (16%) of 115 patients and overt 
proteinuria (UAE>300 mg/d) in only 6 (5%). Plasma glucose, lipids and uric acid levels, and 
HOMA-index were comparable across RI tertiles. Both C-reactive protein and lipoprotein(a) 
had a nonsignificant trend to increase with increasing RI, but plasma homocysteine did not 
change. Plasma fibrinogen and D-dimer levels increased progressively with increasing RI 
(Figure 1), whereas F1+2 and PAI-1 were comparable in patients with different RI.
Univariate correlation analysis indicated that intrarenal RI was significantly and 
directly related to age (r=0.413, P<0.001), systolic blood pressure (r=0.188, P=0.044), pulse 
pressure (r=0.376, P<0.001), HOMA-index (r=0.219, P=0.024), UAE (r=0.195, P=0.038) 
and log D-dimer (r=0.313, P=0.001; Figure 2), and inversely related to GFR (r=-0.326, 
P<0.001). D-dimer levels were significantly higher in women than in men (P=0.024) and 
log transformed values were directly correlated with age (r=0.305, P=0.002), UAE (r=0.256, 
P=0.006) and log fibrinogen levels (r=0.256, P=0.006). Multivariate regression analysis was 
performed including variables that were correlated with RI on univariate analysis, with the 
addition of sex, BMI, and log fibrinogen as independent variables. This analysis showed 
that intrarenal RI was independently associated with pulse pressure, GFR, and log D-dimer 
values (Table 3).
Discussion
In addition to the level of blood pressure, many factors facilitate progression of intrarenal arteriolar damage in hypertensive patients. This type of arteriolar damage is a hallmark of the hypertensive  kidney and can be investigated noninvasively by measurement 
of intrarenal RI [6, 7]. We have investigated the role of the hemostatic system in a large 
group of nondiabetic, hypertensive patients free of cardiovascular complications and 
advanced renal failure. In these patients, we have found that both plasma fibrinogen and 
Table 1. Clinical characteristics of hypertensive patients who were grouped according to tertiles 
of intrarenal resistance index (RI) 
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D-dimer levels increase significantly 
with increasing renal RI. Moreover, 
fibrin D-dimer is associated with 
intrarenal RI independently of age, 
sex, blood pressure, renal function, 
and insulin sensitivity, suggesting that a prothrombotic state might contribute to the increased resistance of intrarenal vessels.
Fibrin D-dimer is the major 
breakdown fragment of fibrin and 
a reliable marker of an existing 
thrombophilia [22]. Measurement 
of D-dimer, in fact, provides an estimation of the overall state of activation of the coagulation system. Prospective studies have 
demonstrated that D-dimer levels are independently associated with 
the risk of stroke [23], myocardial 
infarction [24], and peripheral artery 
disease [25]. Fibrinogen is also a 
major independent risk factor for 
cerebrovascular, coronary artery, and 
peripheral artery disease [26, 27]. A 
combined increase of fibrinogen and 
D-dimer levels therefore indicates 
the existence of a prothrombotic state that might have a role in the development and progression of vascular damage. This role seems to 
Table 2. General biochemistries, hemostatic, and renal function variables of hypertensive patients who 
were grouped according to tertiles of intrarenal resistance index (RI) 
Fig. 1. Box and wiskers plot of plasma fibrinogen (top 
panel) and D-dimer (bottom panel) levels in hypertensive patients who were grouped according to tertiles of renal 
resistance index.
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The technique of renal duplex Doppler ultrasonography has been used to evaluate renal 
blood flow in disease states such as main renal artery stenosis and other diseases involving 
the intrarenal vascular compartment, such as diabetes [28], primary aldosteronism 
[20], and essential hypertension [6, 7, 29]. Distal velocimetric indices obtained with this 
technique reliably assess intrarenal hemodynamics [6, 30]. How much different intrarenal 
vascular beds contribute to increased RI in hypertension is not known, although it is likely 
that the velocimetric indices better explore the preglomerular hemodynamics. Consistent 
with previous studies [7] this study reports a highly significant inverse relationship between 
renal RI and GFR, whereas no association of RI with urinary albumin losses was observed. 
This might be explained by the very low prevalence of microalbuminuria (16%) and overt 
proteinuria (5%) observed in our hypertensive patients most likely due to exclusion of patients with advanced impairment of renal function.
It must be noticed also that increased levels of D-dimer and fibrinogen were reported in hypertensive patients with early impairment of renal function [13]. This might suggest the 
possibility that the association between increased intrarenal RI and prothrombotic factors 
might be just the consequence of the inverse relationship of RI with GFR. However, this should 
not be the case because in our multivariate regression model the relationship of D-dimer 
with RI remained significant even after correction for GFR supporting the possibility of a direct contribution of the prothrombotic state to intrarenal arterial damage.
Limitations of this study should be highlighted. First, the cross-sectional design does not permit to establish evidence of a causal relationship between the prothrombotic state 
and increased intrarenal resistance, although the strength and independence of association 
would suggest so. Second, inclusion in the study of a significant proportion of patients 
who were not treatment-naïve might have introduced, despite a relatively long wash-out 
of antihypertensive drugs, a possible confounder affecting both hemostatic markers and 
Fig. 2. Relationship 
between log D-dimer and intrarenal resistance 
index in 115 hypertensive patients. 
Table 3. Multivariate re-gression analysis with re-
nal resistance index (RI) as the dependent variable
have specific relevance in patients with hypertension 
[8] in whom it was reported that elevated levels of fibrin 
D-dimer and fibrinogen are associated with activation of the renin-angiotensin system [14] and increased 
cardiovascular morbidity [9, 10]. In hypertension, a prothrombotic state was also associated with 
evidence of subclinical organ damage, including left ventricular diastolic dysfunction [11] and carotid intima-media thickening [12]. The present study is 
the first to report the association of a prothrombotic state with increased intrarenal vascular resistance suggesting its possible contribution to the early stages of hypertensive renal damage.
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intrarenal resistance. Relevant to this point is that no significant differences in frequency of use and different classes of antihypertensive drugs were observed in patients with different 
intrarenal resistance index (Table 1). The strengths of this study include its size and the 
ability to control for major determinants of intrarenal vascular resistance after exclusion of patients with potential confounders including diabetes and advanced impairment of renal function. 
ConclusionThis study demonstrates that activation of the hemostatic system is independently associated with higher intrarenal renal resistance in nondiabetic hypertensive patients free of cardiovascular complications and advanced impairment of renal function. This suggests that a prothrombtic state might play a role in the early stages of hypertensive renal disease. 
These findings might have clinical relevance inasmuch as measurement of hemostatic 
markers could be useful for identification of hypertensive patients who have developed or will likely develop hypertensive renal damage. Appropriately designed studies will be 
needed to test the possible benefits of pharmacological interventions on the hemostatic system for renal outcomes of hypertensive patients.
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